Adalimumab is a widely used biologic anti-TNF-α-agent for moderate to severe hidradenitis suppurativa and many other autoimmune diseases, including rheumatoid arthritis, ankylosing spondylitis, Crohn’s disease, and uveitis of the posterior segment. This evidence concerns the gene TNF and Crohn disease.